Hamilton B L, Bevan M J, Parkman R
J Immunol. 1981 Feb;126(2):621-5.
A model for bone marrow transplantation across minor histocompatibility barriers was developed by using mouse strains that were H-2 identical and mutually non-reactive in MLC. Acute graft-vs-host disease was induced only when donor lymphoid cells were included in the marrow inoculum, in both C57BL/6 recipients of LP cells and BALB/c recipients of B10.D2/nSN cells. GVHD was prevented by treating the lymphoid cells with anti-Thy 1.2 and C before transplantation. Spleen cells from mice with acute GVHD were not directly cytotoxic to recipient strain target cells. However, when spleen cells from mice with GVHD were boosted in vitro to recipient strain stimulator cells they generated a specific anti-recipient cytotoxic response. Spleen cells from mice without GVHD did not generate a cytotoxic response in vitro. The cytotoxic effector cells and their precursors were shown to be T lymphocytes. This model and the in vitro method described may be useful in further studies of the immunobiology of GVHD due to minor histocompatibility antigens and of transplantation tolerance.
通过使用在混合淋巴细胞培养(MLC)中H-2相同且相互无反应性的小鼠品系,建立了一个跨越次要组织相容性屏障的骨髓移植模型。仅当供体淋巴细胞包含在骨髓接种物中时,在LP细胞的C57BL/6受体和B10.D2/nSN细胞的BALB/c受体中才会诱导急性移植物抗宿主病(GVHD)。在移植前用抗Thy 1.2和补体(C)处理淋巴细胞可预防GVHD。患有急性GVHD的小鼠的脾细胞对受体品系靶细胞无直接细胞毒性。然而,当患有GVHD的小鼠的脾细胞在体外被受体品系刺激细胞增强时,它们会产生特异性的抗受体细胞毒性反应。没有GVHD的小鼠的脾细胞在体外不会产生细胞毒性反应。细胞毒性效应细胞及其前体被证明是T淋巴细胞。该模型和所描述的体外方法可能有助于进一步研究由于次要组织相容性抗原引起的GVHD的免疫生物学以及移植耐受性。